VIR (STOCKS)
Vir Biotechnology, Inc. Common Stock
$9.000000
+0.040000 (+0.45%)
Prev close: $8.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Marianne de Backer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,532.36M
- Employees
- 408
- P/E (TTM)
- -4.81
- P/B (TTM)
- 1.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.47 | $0.34 | +0.1337 | +39.76% |
|
Mar 2026 (Q1)
|
$-0.85 | $-0.10 | -0.7536 | -781.74% |
|
Dec 2025 (Q4)
|
$-0.31 | $-0.50 | +0.1865 | +37.56% |
|
Sep 2025 (Q3)
|
$-1.17 | $-0.86 | -0.3078 | -35.70% |
Financial Statements
| Revenues | $303.23M |
| Benefits Costs and Expenses | $554.53M |
| Cost Of Revenue | $15.00K |
| Costs And Expenses | $583.41M |
| Nonoperating Income/Loss | $28.89M |
| Operating Expenses | $583.39M |
| Selling, General, and Administrative Expenses | $99.38M |
| Research and Development | $484.02M |
| Operating Income/Loss | -$280.19M |
| Income/Loss From Continuing Operations After Tax | -$251.68M |
| Income/Loss From Continuing Operations Before Tax | -$251.30M |
| Income Tax Expense/Benefit | $380.00K |
| Net Income/Loss | -$251.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$251.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$251.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.84 |
| Diluted Earnings Per Share | -$1.85 |
| Basic Average Shares | 454,238,885 |
| Diluted Average Shares | 455,398,997 |
| Assets | $1.21B |
| Current Assets | $573.74M |
| Noncurrent Assets | $641.07M |
| Fixed Assets | $50.43M |
| Intangible Assets | $7.70M |
| Other Non-current Assets | $582.94M |
| Liabilities | $232.31M |
| Current Liabilities | $94.96M |
| Accounts Payable | $17.75M |
| Other Current Liabilities | $77.21M |
| Noncurrent Liabilities | $137.35M |
| Equity | $982.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $982.49M |
| Liabilities And Equity | $1.21B |
| Net Cash Flow From Operating Activities | -$202.51M |
| Net Cash Flow From Operating Activities, Continuing | -$202.51M |
| Net Cash Flow From Investing Activities | -$58.21M |
| Net Cash Flow From Investing Activities, Continuing | -$58.21M |
| Net Cash Flow From Financing Activities | $242.04M |
| Net Cash Flow From Financing Activities, Continuing | $242.04M |
| Net Cash Flow | -$18.68M |
| Net Cash Flow, Continuing | -$18.68M |
| Comprehensive Income/Loss | -$254.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$254.06M |
| Other Comprehensive Income/Loss | $183.93M |